MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager

Statement of Purpose
Guidelines for Authors
Editorial Board

Recent Issues

April 2009


Health Care and Law

Physician Rights to Privacy of Data Prevail in Two Major Court Tests, But New Questions Lie Ahead

Information about physician behavior, including malpractice judgments, is becoming more public now, especially on the Internet, and many health care professionals are concerned about Web-based patient critiques. Two court cases show that although physician privacy has prevailed, it is expected to face ongoing challenges.
Robert I. Field, JD, MPH, PhD

Pharmacoeconomic Analysis of Micafungin (Mycamine) 100 mg and 150 mg Daily In the Treatment of Candidemia

In a retrospective study, 100 mg of micafungin given once daily was as cost-effective as the 150-mg dose and yielded significant savings of $300 per patient.
Kwaku Marfo, PharmD, BCPS, and Yi Guo, PharmD

Pharmaceutical Approval Update

Topics include febuxostat (Uloric) in managing excess uric acid in gout; Hylan G-F 20 (Synvisc-One) for treating pain in osteoarthritis; and fibrinogen concentrate (RiaSTAP), an orphan drug to treat acute bleeding in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.
Marvin M. Goldenberg, PhD, RPh, MS

Meeting Highlights

Integrative Healthcare Symposium

Cancer and Chronic Lyme Disease

Discussions include supplements and herbs for breast cancer; chemoprotectant ribosomal RNA for advanced cancer; and conventional drugs with complementary therapies for patients with Lyme disease and other tick-borne disorders.
Walter Alexander

Continuing Education Credit

Spontaneous Bacterial Peritonitis

A Review of Treatment Options

Spontaneous bacterial peritonitis (SBP) often affects patients with cirrhosis and ascites. The authors review the pathogenesis and diagnosis of SBP, differentiate between primary SBP and secondary peritonitis, and discuss current therapies.
Cesar Alaniz, PharmD, and Randolph E. Regal, PharmD



R&D Redux

Although skeptics say fixing Big Pharma is not possible, David B. Nash, MD, MBA, describes a “cultural revolution” in which small elite groups within centers of excellence could revitalize R&D.
David B. Nash, MD, MBA

Medication Errors

Preventing Serious Tissue Injury with Intravenous Promethazine (Phenergan)

Matthew Grissinger, RPh, FASCP, highlights the need for vigilance with promethazine (Phenergan), which has caused tragic effects when it was not administered properly.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Comparative Effectiveness Research Produces Contentious Debate — To What End?

Stephen Barlas discusses the challenges facing comparative effectiveness research and how the $1.1 billion from the stimulus package might be divided up.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

From cethromycin to Seroquel, P&T presents the latest data on FDA approvals, indications, and industry updates.

Drug Forecast

Nebivolol (Bystolic), a Novel Beta Blocker for Hypertension

Drs. Hilas and Ezzo review nebivolol (Bystolic), a beta blocker for hypertension.
Olga Hilas, PharmD, BCPS, CGP, and Danielle Ezzo, PharmD, BCPS, CGP